Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
627
-
Total 13F shares, excl. options
-
258M
-
Shares change
-
+10.7M
-
Total reported value, excl. options
-
$12.9B
-
Value change
-
+$534M
-
Put/Call ratio
-
0.11
-
Number of buys
-
308
-
Number of sells
-
-216
-
Price
-
$50.03
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q2 2022
689 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q2 2022.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 627 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 258M shares
of 1.23B outstanding shares and own 21.03% of the company stock.
Largest 10 shareholders include Dodge & Cox (77M shares), FMR LLC (18.7M shares), Fisher Asset Management, LLC (17.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (17.2M shares), BANK OF AMERICA CORP /DE/ (13.5M shares), BlackRock Inc. (13M shares), Boston Partners (11.9M shares), MORGAN STANLEY (6.11M shares), Invesco Ltd. (5.39M shares), and Camber Capital Management LP (4M shares).
This table shows the top 627 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.